Funding Opportunities

Titlesort ascending Announcement # Expiration Date Research Focus
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-18-913 (U01 Clinical Trial Not Allowed) 08/12/2021
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    • Early Detection
Symptom Cluster Characterization in Chronic Conditions PA-17-462 (R01) 01/08/2021
    • Supportive Care and Symptom Management
Symptom Cluster Characterization in Chronic Conditions PA-17-461 (R21) 01/08/2021
    • Supportive Care and Symptom Management
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants PAR-17-003 (R01) 10/29/2019
    • Gastrointestinal and Other Cancers
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies PA-18-025 (R01 Clinical Trial Optional) 05/08/2020
    • Breast and Gynecologic Cancer
    • Chemopreventive Agent Development
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-893 (R01 Clinical Trial Optional) 09/08/2021
    • Nutritional Science
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-892 (R21 Clinical Trial Optional) 09/08/2021
    • Nutritional Science
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) PA-18-004 (R01 Clinical Trial Optional) 01/08/2020
    • Supportive Care and Symptom Management
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-18-014 (R21 Clinical Trial Optional) 01/08/2020
    • Supportive Care and Symptom Management
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine PAR-18-841 (U24 - Clinical Trial Optional) 06/15/2021
    • Cancer Biomarkers
NCI Outstanding Investigator Award PAR-19-349 (R35 Clinical Trial Not Allowed) 11/07/2019
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
NCI Clinical and Translational Exploratory/Developmental Studies PAR-19-356 (R21 Clinical Trial Optional) 07/21/2022
    • Breast and Gynecologic Cancer
National Cancer Institute Program Project Applications PAR-18-290 (P01 Clinical Trial Optional) 01/08/2020
    • Chemopreventive Agent Development
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer PAR-19-199 (R21 Clinical Trial Not Allowed) 11/09/2021
    • Nutritional Science
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer PAR-19-198 (R01 Clinical Trial Not Allowed) 11/09/2021
    • Nutritional Science
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-112 (R01 Clinical Trial Optional) 01/08/2022
    • Supportive Care and Symptom Management
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-111 (R21 Clinical Trial Optional) 01/08/2022
    • Supportive Care and Symptom Management
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer PAR-19-264 (R01 Clinical Trial Optional) 12/11/2021
    • Consortium for Imaging and Biomarkers
    • Cancer Biomarkers
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 (R21 Clinical Trial Optional) 05/08/2021
    • Nutritional Science
Diet and Physical Activity Assessment Methodology PAR-18-857 (R21 Clinical Trial Not Allowed) 09/08/2021
    • Nutritional Science
Diet and Physical Activity Assessment Methodology PA-18-856 (R01 Clinical Trial Not Allowed) 09/08/2021
    • Nutritional Science
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-19-325 (R01 Clinical Trial Optional) 02/12/2022
    • Community Oncology and Prevention Trials
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-19-113 (R01 Clinical Trial Optional) 01/08/2022
    • Cancer Biomarkers
Cancer Prevention and Control Clinical Trials Grant Program PAR-18-559 (R01 Clinical Trial Required) 01/08/2021
    • Breast and Gynecologic Cancer
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Prostate and Urologic Cancer
Biology of Lung, and Head and Neck Preneoplasias PA-17-460 (R21 - Clinical Trial Not Allowed) 01/08/2021
    • Lung and Upper Aerodigestive Cancer
Biology of Lung, and Head and Neck Preneoplasias PA-17-459 (R01) 01/08/2021
    • Lung and Upper Aerodigestive Cancer
Biology of Bladder Cancer PAR-19-183 (R01 Clinical Trial Optional) 05/08/2022
    • Prostate and Urologic Cancer
Biology of Bladder Cancer PAR-19-184 (R21 Clinical Trial Optional) 05/08/2022
    • Prostate and Urologic Cancer
Basic Research in Cancer Health Disparities PAR-18-654 (R01 Clinical Trials Not Allowed) 11/20/2020
    • Community Oncology and Prevention Trials
Basic Research in Cancer Health Disparities PAR-18-655 (R21 Clinical Trial Not Allowed) 11/20/2020
    • Community Oncology and Prevention Trials
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-251 (R01 Clinical Trial Optional) 11/09/2021
    • Adductomics Research Program
    • Cancer Biomarkers
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-252 (R21 Clinical Trial Optional) 11/09/2021
    • Adductomics Research Program
    • Cancer Biomarkers
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed PAR-18-310 10/09/2020
    • Cancer Biomarkers
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) PAR-18-317 10/09/2020
    • Cancer Biomarkers
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression ( PA-18-739 (R21 Clinical Trial Optional) 05/08/2021
    • Nutritional Science
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression PA-18-738 (R01 Clinical Trial Optional) 05/08/2021
    • Nutritional Science
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research PA-18-902 (R01 Clinical Trial Optional) 09/08/2021
    • Cancer Biomarkers
Advancing the Science of Geriatric Palliative Care PA-18-503 (R21 - Clinical Trial Optional) 05/08/2020
    • Supportive Care and Symptom Management
Advancing the Science of Geriatric Palliative Care PA-18-502 (R01 - Clinical Trial Optional) 05/08/2020
    • Supportive Care and Symptom Management
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research PA-18-876 (R01 Clinical Trial Not Allowed) 09/08/2021
    • Nutritional Science
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) PA-18-842 09/11/2020
    • Breast and Gynecologic Cancer
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Prostate and Urologic Cancer
Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) PA-18-818 04/16/2020
    • Nutritional Science
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) PA-18-817 04/16/2020
    • Nutritional Science
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems PAR-18-009 (R01 Clinical Trial Optional) 11/06/2019
    • Cancer Biomarkers